About
Damien McDevitt is a biotech executive and board member who serves as President and Chief Executive Officer of Aspen Neuroscience. He previously served as CEO and director of Akcea Therapeutics and held senior corporate development roles at Ionis Pharmaceuticals, ACADIA Pharmaceuticals, and GlaxoSmithKline. His background centers on neuroscience, rare disease, business development, and strategic partnering in biopharma.
Areas of interest
biotechpharmaceuticalsneuroscienceParkinson's diseasecell therapyrare diseasescorporate developmentbusiness developmentstrategic partnerships